Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

UKPDS publications in Diabetologia

UKPDS publications in Diabetologia

07-26-2021 | Glycemic control | News

Delayed impact of high glucose levels may explain legacy effect

The so-called legacy effect of a period of good glycemic control in type 2 diabetes may be because the greatest impact of hyperglycemia occurs many years in the future, show data from the UKPDS.

11-11-2016 | Type 1 diabetes | Editorial | Article

World Diabetes Day, 14 November 2016

A call to action from editorial board member Lori Berard.

06-22-2013 | Epidemiology | Article

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study

Hayes AJ et al. Diabetologia 2013; 56: 1925–1933. doi: 10.1007/s00125-013-2940-y

08-05-2009 | Cardiovascular outcomes | Article

Intensive glucose control and macrovascular outcomes in type 2 diabetes

Turnbull FM et al. Diabetologia 2009; 52: 2288–2298. doi: 10.1007/s00125-009-1470-0 

12-02-2006 | Latent autoimmune diabetes of adulthood | Article

An association analysis of the HLA gene region in latent autoimmune diabetes in adults

Desai M et al. Diabetologia 2007; 50: 68–73. doi: 10.1007/s00125-006-0513-z

10-03-2006 | Nephropathy | Article

Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes

Calle R et al. Diabetologia 2006; 49: 2892–2899. doi: 10.1007/s00125-006-0436-8

05-31-2006 | Hypertension | Article

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: A prospective observational study

Stratton IM et al. Diabetologia 2006; 49: 1761–1769. doi: 10.1007/s00125-006-0297-1

04-15-2005 | Hypertension | Article

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes

Clarke PM et al. Diabetologia 2005; 48: 868–877. doi: 10.1007/s00125-005-1717-3

03-12-2005 | Pathophysiology | Article

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes

Bottazzo GF et al. Diabetologia 2005; 48: 703–708. doi: 10.1007/s00125-005-1691-9

02-24-2005 | Pathophysiology | Article

Islet autoantibodies in clinically diagnosed type 2 diabetes: Prevalence and relationship with metabolic control

Davis TME et al. Diabetologia 2005; 48: 695–702. doi: 10.1007/s00125-005-1690-x

10-27-2004 | Type 2 diabetes | Article

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model

Clarke PM et al. Diabetologia 2004; 47: 1747–1759. doi: 10.1007/s00125-004-1527-z

12-01-2001 | Genetics | Article

Butyrylcholinesterase K variant on chromosome 3 q is associated with type 2 diabetes in white Caucasian subjects

Hashim Y et al. Diabetologia 2001; 44: 2227–2230. doi: 10.1007/s001250100033

03-01-2001 | Metformin | Article

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type 2 diabetes

Clarke P et al. Diabetologia 2001; 44: 298–304. doi: 10.1007/s001250051617

02-01-2001 | Retinopathy | Article

Risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis

Stratton IM et al. Diabetologia 2001; 44: 1546–1563. doi: 10.1007/s001250051594

09-01-1999 | Genetics | Article

Sequence variants of the sarco(endo)plasmic reticulum Ca2+-transport ATPase 3 gene (SERCA3) in Caucasian type 2 diabetic patients

Varadi A et al. Diabetologia 1999; 42: 1240–1243. doi: 10.1007/s001250051298

08-01-1999 | Retinopathy | Article

Microaneurysms in the development of diabetic retinopathy

Kohner EM et al. Diabetologia 1999; 42: 1107–1112. doi: 10.1007/s001250051278

04-01-1999 | Genetics | Article

Genetic heterogeneity of autoimmune diabetes: Age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes

Horton VA et al. Diabetologia 1999; 42: 608–616. doi: 10.1007/s001250051202

06-01-1997 | Cardiovascular disorders | Article

Coronary heart disease and risk factors in NIDDM: Experience from the United Kingdom Prospective Diabetes Study

Turner RC, Millns H, Holman RR. Diabetologia 1997; 40 (Suppl 2): S121–S122. doi: 10.1007/s001250051424

11-01-1996 | Genetics | Article

Heterogeneity in NIDDM: Separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations

Zhang Y et al. Diabetologia 1996; 39: 1505–1511. doi: 10.1007/s001250050605

08-01-1995 | Cardiovascular disorders | Article

Association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM

Keavney BD et al. Diabetologia 1995; 38: 948–952. doi: 10.1007/BF00400584

Next
Image Credits